Bayesian Analysis of a Physiologically Based Pharmacokinetic Model for Perchloroethylene in Humans
暂无分享,去创建一个
Junshan Qiu | Yeh-Chung Chien | J. Qiu | Yeh-Chung Chien | J. Bruckner | J. Fisher | James V Bruckner | Jeffery W Fisher
[1] William K Boyes,et al. Momentary brain concentration of trichloroethylene predicts the effects on rat visual function. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[2] E. Lederer,et al. Biotransformation of perchloroethene: dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-L-cysteine in rats and humans after inhalation. , 1998, Toxicology and applied pharmacology.
[3] C. Dallas,et al. Development of a physiologically based pharmacokinetic model for perchloroethylene using tissue concentration-time data. , 1994, Toxicology and applied pharmacology.
[4] F Y Bois,et al. Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics. , 2000, Environmental health perspectives.
[5] C. Mitoma,et al. Metabolic disposition study of chlorinated hydrocarbons in rats and mice. , 1985, Drug and chemical toxicology.
[6] P. Gustafson,et al. Conservative prior distributions for variance parameters in hierarchical models , 2006 .
[7] A C Monster,et al. Kinetics of tetrachloroethylene in volunteers; influence of exposure concentration and work load , 1979, International archives of occupational and environmental health.
[8] A. Gelman,et al. Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions , 1996 .
[9] A. Fan. Public Health Goal for TETRACHLOROETHYLENE In Drinking Water , 2001 .
[10] U. Krämer,et al. Neurobehavioral and neurophysiological outcome of chronic low-level tetrachloroethene exposure measured in neighborhoods of dry cleaning shops. , 1995, Environmental research.
[11] D. Raines,et al. The N-Methyl-d-aspartate Receptor Inhibitory Potencies of Aromatic Inhaled Drugs of Abuse: Evidence for Modulation by Cation-π Interactions , 2004, Journal of Pharmacology and Experimental Therapeutics.
[12] B. Blount,et al. Quantification of 31 volatile organic compounds in whole blood using solid-phase microextraction and gas chromatography-mass spectrometry. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] P. Bushnell,et al. Volatile organic compounds inhibit human and rat neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. , 2005, Toxicology and applied pharmacology.
[14] A. Seeber,et al. Neurobehavioral toxicity of long-term exposure to tetrachloroethylene. , 1989, Neurotoxicology and teratology.
[15] D. Werren,et al. Oxidative stress and DNA damage in Fischer rats following acute exposure to trichloroethylene or perchloroethylene. , 1999, Toxicology.
[16] P. Squillace,et al. Chlorinated solvents in groundwater of the United States. , 2007, Environmental science & technology.
[17] B. Orser,et al. Emerging molecular mechanisms of general anesthetic action. , 2005, Trends in pharmacological sciences.
[18] Harvey J Clewell,et al. Use of Markov Chain Monte Carlo Analysis with a Physiologically‐Based Pharmacokinetic Model of Methylmercury to Estimate Exposures in U.S. Women of Childbearing Age , 2007, Risk analysis : an official publication of the Society for Risk Analysis.
[19] L. Sheiner,et al. Evaluating Pharmacokinetic/Pharmacodynamic Models Using the Posterior Predictive Check , 2001, Journal of Pharmacokinetics and Pharmacodynamics.
[20] P. Watanabe,et al. Disposition of tetrachloro(14C)ethylene following oral and inhalation exposure in rats. , 1979, Toxicology and applied pharmacology.
[21] Adrian Raftery,et al. The Number of Iterations, Convergence Diagnostics and Generic Metropolis Algorithms , 1995 .
[22] F. Bois,et al. Toxicokinetics of inhaled trichloroethylene and tetrachloroethylene in humans at 1 ppm: empirical results and comparisons with previous studies. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[23] Harvey J Clewell,et al. Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites. , 2006, Regulatory toxicology and pharmacology : RTP.
[24] H. Wiegand,et al. Neurophysiological and psychophysical measurements reveal effects of acute low-level organic solvent exposure in humans , 1990, International archives of occupational and environmental health.
[25] G. Winneke,et al. Neurobehavioural and Neurophysiological Outcomes of Acute Repeated Perchloroethylene Exposure , 1992 .
[26] P. Bushnell,et al. Developing an exposure-dose-response model for the acute neurotoxicity of organic solvents: overview and progress on in vitro models and dosimetry. , 2005, Environmental toxicology and pharmacology.
[27] Harvey J Clewell,et al. Evaluation of Physiologically Based Pharmacokinetic Models in Risk Assessment: An Example with Perchloroethylene , 2005, Critical reviews in toxicology.
[28] E. Gubéran,et al. Experimental human exposures to tetrachloroethylene vapor and elimination in breath after inhalation. , 1976, American Industrial Hygiene Association journal.
[29] H J Clewell,et al. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). , 1993, Toxicology letters.
[30] J. Buben,et al. Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: a dose-effect study. , 1985, Toxicology and applied pharmacology.
[31] Xiao-Li Meng,et al. POSTERIOR PREDICTIVE ASSESSMENT OF MODEL FITNESS VIA REALIZED DISCREPANCIES , 1996 .
[32] Harvey J Clewell,et al. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene. , 2007, Regulatory toxicology and pharmacology : RTP.
[33] L. Lash,et al. Hepatic and renal toxicities associated with perchloroethylene. , 2001, Pharmacological reviews.
[34] Weihsueh A. Chiu,et al. Revisiting the population toxicokinetics of tetrachloroethylene , 2006, Archives of Toxicology.
[35] P. Stewart,et al. Extended mortality follow-up of a cohort of dry cleaners. , 2003, Annals of epidemiology.
[36] F Y Bois,et al. Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. , 2000, Environmental health perspectives.
[37] A. Gelman. Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper) , 2004 .
[38] R J Bull,et al. Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate. , 2000, Environmental health perspectives.
[39] K. Mundt,et al. Critical review of the epidemiological literature on occupational exposure to perchloroethylene and cancer , 2003, International archives of occupational and environmental health.
[40] Michigan.,et al. Toxicological profile for dichloropropenes , 2008 .
[41] A. Stemhagen,et al. Occupational risk factors and liver cancer. A retrospective case-control study of primary liver cancer in New Jersey. , 1983, American journal of epidemiology.
[42] Peter Green,et al. Markov chain Monte Carlo in Practice , 1996 .
[43] Sylvia Richardson,et al. Inference and monitoring convergence , 1995 .
[44] F. A. Smith,et al. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.
[45] A. Gelman,et al. Population toxicokinetics of tetrachloroethylene , 1996, Archives of Toxicology.
[46] Yee-Wan Stevens,et al. Toxicological profile for tetrachloroethylene , 1997 .
[47] P. Watanabe,et al. Tetrachloroethylene: balance and tissue distribution in male Sprague-Dawley rats by drinking-water administration. , 1983, Toxicology and applied pharmacology.
[48] Y. Hwang,et al. Increased mortality odds ratio of male liver cancer in a community contaminated by chlorinated hydrocarbons in groundwater , 2003, Occupational and environmental medicine.
[49] P. Romundstad,et al. Cancer in Persons Working in Dry Cleaning in the Nordic Countries , 2005, Environmental health perspectives.
[50] M. Metzler,et al. Identification of S-1,2,2-trichlorovinyl-N-acetylcysteine as a urinary metabolite of tetrachloroethylene: bioactivation through glutathione conjugation as a possible explanation of its nephrocarcinogenicity. , 1986, Journal of biochemical toxicology.